Aarti Drugs Ltd share price logo

Aarti Drugs Share Price

NSE: AARTIDRUGS

BSE: 524348

Small Cap

Healthcare Sector

₹357.10

-3.70

(-1.03%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Aarti Drugs Stock Performance

as on March 6, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹356.10
    ₹362.70
    downward going graph

    0.28%

    Downside

    1.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹312.00
    ₹564.05
    downward going graph

    12.63%

    Downside

    57.95%

    Upside

    downward going graph

Aarti Drugs share price movements today

Previous Close
₹360.80
Open
₹360.80
Volume
52.51K
Upper Circuit
₹432.95
Lower Circuit
₹288.65
Day's Low - High
₹356.10 - ₹362.70
52 Week Low - High
₹312.00 - ₹564.05

Aarti Drugs Historical Returns

1 Month Return
-5.32 %
3 Month Return
-10.27 %
1 Year Return
-1.72 %
3 Year Return
+ 1.29 %
5 Year Return
-47.6 %

Aarti Drugs Fundamentals

as on March 6, 2026 at 4:01 pm IST

Market Cap

₹3,259.25 Cr

Return on Equity (ROE)

12.97

PE Ratio (TTM)

16.1

Return on capital employed (ROCE)

13.49

Industry PE ratio

42.07

Beta (LTM)

0.98

P/B Ratio

2.48

Dividend Yield

0.29

PEG Ratio

2.92

Quarterly Earnings Growth YOY

9.33

EPS (TTM)

18.42

Sector

Pharmaceuticals

Book Value

149.99

Technical Analysis

Bearish

View Technical Analysis

Aarti Drugs Stock Valuation

as on March 6, 2026 at 4:01 pm IST

Aarti Drugs in the last 5 years

  • Overview

  • Trends

Lowest (8.29x)

March 31, 2020

Today (16.10x)

March 6, 2026

Industry (42.07x)

March 6, 2026

Highest (57.24x)

August 24, 2020

LowHigh

Today’s Price to Earnings Ratio: 16.10x

Aarti Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarti Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aarti Drugs Ltd image
Aarti Drugs Ltd
HOLD3,259.25-9.52%0.661682,387
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY10,708.05-8.42%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY13,031.541.33%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY4,022.77-5.17%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,181.0133.28%0.672441,515
See all

Market expectation of Aarti Drugs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Aarti Drugs Stock’s Investor Sentiment and Interest

Search interest for Aarti Drugs Ltd Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Aarti Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
742.41
661.11
641.54
605.94
619.99
555.34
598.33
556.6
676.76
590.51
652.79
601.71
Other Income
0.87
0.6
0.69
1.67
1.08
1.11
1.48
11.9
1.87
0.31
0.09
1.23
Total Income
743.28
661.71
642.23
607.61
621.07
556.45
599.81
568.5
678.63
590.82
652.88
602.94
Expenses
648.87
577.04
565.1
535.8
534.18
490.38
531.28
494.87
583.43
516.43
568.51
546.68
Operating Profit
93.54
84.07
76.44
70.14
85.81
64.96
67.05
61.73
93.33
74.08
84.28
55.03
Operating Profit Margin %
12.6%
12.72%
11.92%
11.58%
13.84%
11.7%
11.21%
11.09%
13.79%
12.55%
12.91%
9.15%
Profit Before Interest, Tax and Depreciation
94.41
84.67
77.13
71.81
86.89
66.07
68.53
73.63
95.2
74.39
84.37
56.26
Interest
8.63
8.54
8.25
7.6
9.13
8.71
8.93
9.07
9.16
8.56
7.7
9.29
Depreciation
12.5
12.6
12.61
12.66
13.58
13.38
13.72
13.8
14.88
14.72
16.26
17.95
Profit Before Tax
73.28
63.53
56.27
51.55
64.18
43.98
45.88
50.76
71.16
51.11
60.41
29.02
Tax Paid
17.1
15.56
16.67
14.84
16.87
10.71
10.92
13.67
8.39
-2.86
15.25
-11.53
Profit After Tax
56.18
47.97
39.6
36.71
47.31
33.27
34.96
37.09
62.77
53.97
45.16
40.55
Total Net profit including share of profit / Loss from associate company
56.18
47.97
39.6
36.71
47.31
33.27
34.96
37.09
62.77
53.97
45.16
40.55
EPS
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
Actual EPS
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
Adjusted EPS
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
Diluted EPS
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44

Aarti Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,195.17
1,243.63
1,560.94
1,806.09
2,154.78
2,488.65
2,716.05
2,528.58
2,387.03
Other Income
4
1.05
6.18
5.95
4.74
11.32
2.19
4.03
16.36
Total Income
1,199.17
1,244.68
1,567.12
1,812.04
2,159.52
2,499.97
2,718.24
2,532.61
2,403.39
Expenses
1,008.28
1,045.15
1,353.58
1,544.27
1,717.67
2,159.21
2,410.45
2,212.12
2,099.97
Operating Profit
186.89
198.48
207.36
261.82
437.11
329.44
305.6
316.46
287.06
Operating Profit Margin %
15.64%
15.96%
13.28%
14.5%
20.29%
13.24%
11.25%
12.52%
12.03%
Profit Before Interest, Tax and Depreciation
190.89
199.53
213.54
267.77
441.85
340.76
307.79
320.49
303.42
Interest
36.42
34.96
39.96
33.73
22.96
20.75
33.29
33.52
35.87
Depreciation
38.46
40.06
42.56
48.75
49.88
50.05
50.32
51.45
55.78
Profit Before Tax
116.01
124.51
131.02
185.29
369.01
269.96
224.18
235.52
211.77
Tax Paid
34.21
42.2
41.27
43.89
88.61
64.96
57.82
63.93
43.67
Profit After Tax
81.8
82.31
89.75
141.4
280.4
205
166.36
171.59
168.1
Total Net profit including share of profit / Loss from associate company
81.8
82.31
89.75
141.4
280.4
205
166.36
171.59
168.1
EPS
33.46
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
Actual EPS
33.46
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
Adjusted EPS
8.37
8.6
9.62
15.14
30.09
22.12
17.97
18.56
18.35
Diluted EPS
33.46
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35

Aarti Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
133.3
174.75
69.77
143.09
250.74
154.95
70.41
133.32
358.92
244.58
Cash Flow from Investing Activities
-98.79
-106.97
-73.54
-61.67
-33.21
-71.77
-149.63
-163.97
-223.64
-164.63
Cash Flow from Financing Activities
-33.26
-68.22
3.92
-80.06
-215.42
-81.14
92.02
16.55
-136.03
-82.12
Net Cash Flow
1.24
-0.45
0.15
1.35
2.13
2.04
12.8
-14.11
-0.76
-2.17

Aarti Drugs Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
58.7%
58.56%
57.47%
57.13%
55.67%
55.64%
55.38%
55.48%
55.22%
54.72%
55.03%
DII
4.71%
5.32%
5.26%
5.99%
7.35%
7.84%
8.77%
9.7%
9.94%
9.9%
10.12%
FII
0%
2.33%
2.1%
2.56%
2.96%
2.5%
2.28%
2.25%
2.26%
2.69%
2.15%
Public
34.62%
33.79%
35.17%
34.31%
34.02%
34.02%
33.57%
32.57%
32.58%
32.69%
32.7%
Total Outstanding Shares
9,26,00,000
9,19,35,000
9,19,35,000
9,19,35,000
9,19,35,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
9,12,70,000
Total Shareholders
1,62,409
1,67,446
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006
1,69,761
1,60,260
1,52,252
1,48,363

Mutual Funds that own Aarti Drugs Stock

Check out the Mutual Funds with significant holdings in Aarti Drugs.

Aarti Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Aarti Drugs.

  • Aarti Drugs Ltd Earnings Results

    Aarti Drugs Ltd’s net profit jumped 9.42% since last year same period to ₹40.54Cr in the Q3 2025-2026. On a quarterly growth basis, Aarti Drugs Ltd has generated -10.47% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Aarti Drugs Ltd Dividends February,2026

    In the quarter ending December 2025, Aarti Drugs Ltd has declared dividend of ₹2.00 per share on 03 Feb 2026 - translating a dividend yield of 0.55%.

    Read More about Dividends

Indices Featuring Aarti Drugs Stock

Check stock indices that include Aarti Drugs.

BSE Healthcare

₹43,557.88

-0.27 (▲116.17%)

Insights on Aarti Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 32.69% to 32.70% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 54.72% to 55.03% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 9.81% to 10.03% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 185.3% return, outperforming this stock by 185.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 40.6% return, outperforming this stock by 42.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 652.88 Cr → 602.94 Cr (in ₹), with an average decrease of 7.7% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.69% to 2.15% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, AARTIDRUGS stock has moved down by -25.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 62.86 Cr → 40.54 Cr (in ₹), with an average decrease of 13.6% per quarter

About Aarti Drugs Ltd

Aarti Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. Part of the USD 1500 million Aarti Group, it has two RD divisions in Tarapur and Turbhe, Maharashtra; and three wholly-owned subsidiaries, namely Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA, a foreign subsidiary. It has expanded its production capacity from 598,000kg in 1993 to 25,716,000kg in 2021. In 2020 it incorporated two overseas subsidiaries and one domestic one, while the one in 2021 was wound up as it didn’t have any business activity. Aarti Drugs also carries out research and development on key products such as antihistaminic/antiallergic, antiinflammatory and antidiabetic. Its GMP-certified plant can manufacture Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. With 50 compounds formed for Antibiotics, Anti Protozoal, AntiInflammatory, Antidiabetic, Anti Fungal and Cardioprotectant therapeutic segments, it is a market leader in API segment.

Revenue: ₹601.71Cr as on December 2025 (Q3 FY26)
Net Profit: ₹40.55Cr as on December 2025 (Q3 FY26)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
OrganisationAarti Drugs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPrakash M Patil
E-voting on sharesClick here to vote

FAQs

What is Aarti Drugs share price today?

Aarti Drugs share price today stands at ₹357.1 as on . Aarti Drugs share today touched a day high of ₹362.7 and a low of ₹356.1.

What is the 52 week high and 52 week low range for Aarti Drugs share?

Aarti Drugs touched a 52 week high of ₹564.05 and a 52 week low of ₹312. Aarti Drugs share price today i.e. is trending at ₹357.1, which is -36.69% down from its 52 week high and 14.46% up from its 52 week low.

What is Aarti Drugs's market capitalisation today?

Aarti Drugs market capitalisation is ₹3,259.25 Cr as on .

How to buy Aarti Drugs shares?

To buy Aarti Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AARTIDRUGS or Aarti Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarti Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarti Drugs trading volume today?

Aarti Drugs trading volume is 52.51K as on . This means that 52.51K shares of Aarti Drugs were bought and sold on the stock market during today's trading session.